Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Syndax Pharmaceuticals Inc (1T3.BE)

12.00
-0.50
(-4.00%)
At close: May 2 at 9:52:09 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
23,680
23,680
--
--
139,709
Cost of Revenue
826
826
--
--
--
Gross Profit
22,854
22,854
--
--
--
Operating Expense
362,526
362,526
229,954
151,757
113,489
Operating Income
-339,672
-339,672
-229,954
-151,757
26,220
Net Non Operating Interest Income Expense
21,161
21,161
20,955
2,735
-1,496
Other Income Expense
-247
-247
-361
-316
202
Pretax Income
-318,758
-318,758
-209,360
-149,338
24,926
Net Income Common Stockholders
-318,758
-318,758
-209,360
-149,338
24,926
Diluted NI Available to Com Stockholders
-318,758
-318,758
-209,360
-149,338
24,926
Basic EPS
-3.64
-3.72
-2.98
-2.46
0.48
Diluted EPS
-3.64
-3.72
-2.98
-2.46
0.48
Basic Average Shares
82,116.85
85,622.07
70,370.52
60,760.91
52,064.81
Diluted Average Shares
82,116.85
85,622.07
70,370.52
60,760.91
52,064.81
Total Operating Income as Reported
-339,672
-339,672
-229,954
-151,757
26,220
Total Expenses
363,352
363,352
229,954
151,757
113,489
Net Income from Continuing & Discontinued Operation
-318,758
-318,758
-209,360
-149,338
24,926
Normalized Income
-318,758
-318,758
-209,360
-149,338
24,926
Interest Income
26,090
26,090
21,163
5,872
403
Interest Expense
4,929
4,929
208
3,137
1,899
Net Interest Income
21,161
21,161
20,955
2,735
-1,496
EBIT
-313,829
-313,829
-209,152
-146,201
26,825
EBITDA
-313,821
-313,821
-209,140
-146,168
26,868
Reconciled Cost of Revenue
826
826
--
--
--
Reconciled Depreciation
8
8
12
33
43
Net Income from Continuing Operation Net Minority Interest
-318,758
-318,758
-209,360
-149,338
24,926
Normalized EBITDA
-313,821
-313,821
-209,140
-146,168
26,868
12/31/2021 - 4/30/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VX1.MU Vertex Pharmaceuticals Inc
439.25
-0.82%
 
HTD.SG Corcept Therapeutics Inc
64.08
+1.65%
 
VX1.HA Vertex Pharmaceuticals Inc
439.60
-0.92%
 
VX1.DU Vertex Pharmaceuticals Inc
440.35
-0.94%
 
0OT.DU Ocular Therapeutix Inc
7.67
+4.78%
 
VRTX.VI Vertex Pharmaceuticals Incorporated
440.30
-1.21%
 
VX1.BE Vertex Pharmaceuticals Inc
444.00
+0.90%
 
VX1.HM Vertex Pharmaceuticals Inc
439.65
-0.91%
 
ALZCUR.ST AlzeCure Pharma AB (publ)
2.4500
+3.38%
 
AC6.F AlzeCure Pharma AB (publ)
0.1755
-0.85%